Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;77(6):879-886.
doi: 10.1007/s00228-020-03076-8. Epub 2021 Jan 5.

CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients

Janaína B F Everton  1   2 , Fernando J B Patrício  1 , Manuel S Faria  2   3 , Teresa C A Ferreira  4 , Elen A Romao  5 , Gyl E B Silva  2   6 , Marcelo Magalhães  7   8   9
Affiliations

CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients

Janaína B F Everton et al. Eur J Clin Pharmacol. 2021 Jun.

Abstract

Purpose: Genetic polymorphisms have been associated with variation in the metabolism of tacrolimus (TAC) in kidney transplant patients. This study is aimed at assessing the impact of allelic variants of CYP3A5 and PPARA genes on the pharmacokinetics (PK) of TAC in Brazilian kidney transplant recipients in the first-year post-transplant.

Methods: A total of 127 patients were included for genetic evaluation. Genomic DNA was isolated from peripheral blood and real-time PCR was used to analyze the main polymorphisms described for the genes CYP3A5 (rs776746; C > G) and PPARA (rs4823613; A > G and rs4253728; G > A).

Results: CYP3A5 expressors showed a lower Co/dose ratio than non-expressors, with the median values of this parameter <1.01 ng/mL/mg in the first group at all evaluated times. Additionally, PPARA variant homozygotes had a lower Co/D ratio than wild allele carriers in the 12-month post-transplant period, with a median value of 0.65 ng/mL/mg. In the CYP3A5 expressers, the presence of the variant homozygous genotype PPARA was associated with a lower value of Co/D compared with the other genotypic groups at month 12.

Conclusion: In the population under study, polymorphisms on CYP3A5 and PPARA were identified as determining and independent factors associated with the reduction of Co/D of TAC. Thus, the genotyping of these genetic variants may be a useful tool for the individualized prescription of TAC in kidney transplant patients.

Keywords: CYP3A5; Co/D ratio; Kidney transplantation; PPARA; Pharmacokinetics; Tacrolimus.

PubMed Disclaimer

References

    1. Wu DA, Watson CJ, Bradley JA, Johnson RJ, Forsythe JL, Onisci GC (2017) Global trends and challenges in deceased donor kidney allocation. Kidney Int 91:1287–1299. https://doi.org/10.1016/j.kint.2016.09.054 - DOI - PubMed
    1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, Mcintosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612. https://doi.org/10.1056/NEJM200003023420901 - DOI - PubMed
    1. Vincenti F, Jensik SC, Filo RS, Miller J, Pirschet J (2002) A long-term comparison of tacrolimus [FK 506] and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 73:775–782 0041-1337/02/7305-775/0 - DOI
    1. Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715–2729. https://doi.org/10.1056/NEJMra033540 - DOI - PubMed
    1. Du S, Hiramatsu N, Hayakawa K, Hayakawa K, Kasai Y, Okamura M et al (2009) Suppression of NF-κB by cyclosporin A and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol 182:7201–7211. https://doi.org/10.4049/jimmunol.0801772 - DOI - PubMed

LinkOut - more resources